foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer
Pay in 4 interest-free payments of $5.81 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





.png.jpg)





















